CAJ | 학술논문

目的：探讨环磷腺苷葡胺（MCA）治疗尿素症性心肌病的效果。方法：回顾性分析49例尿毒症心肌病患者的病例资料。结果：尿毒症心肌病在常规治疗基础上辅以环磷腺苷葡胺治疗，MCA可以改善尿毒症心肌病患者左心功能，且疗效优于对照组(P<0.05或P<0.01)；MCA治疗在一定时间内改善左室结构且优于对照组，差异有统计学意义(P<0.05或P<0.001)。结论：在常规治疗基础上辅以MCA治疗对尿毒症性心肌病具有较好的治疗效果。
목적：탐토배린선감포알（MCA）치료뇨소증성심기병적효과。방법：회고성분석49례뇨독증심기병환자적병례자료。결과：뇨독증심기병재상규치료기출상보이배린선감포알치료，MCA가이개선뇨독증심기병환자좌심공능，차료효우우대조조(P<0.05혹P<0.01)；MCA치료재일정시간내개선좌실결구차우우대조조，차이유통계학의의(P<0.05혹P<0.001)。결론：재상규치료기출상보이MCA치료대뇨독증성심기병구유교호적치료효과。
Objective:to discuss the efficacy of Meglumine Adenosine Cyclophosphate in treating uremic car-diomyopathy. Method:retrospective analysis of 49 cases of uremic cariomypopathy patients data.Results:Meglumine adenosine cyclophosphate (MCA), with the help of Conventional treatment, can improve left heart function in uremic cardiomyopathy patients .we find MCA has benefit in treating uremic cardiomyopathy compared with control group (P<0.05 OR P<0.01),and it can prevent ventricular remodeling compared with control group(P<0.05 OR P<0.01).Con-clusion:Regular treatment combined with MCA has favorable treatment efficacy for uremic cariomyopathy.